Provided by Tiger Trade Technology Pte. Ltd.

Memphasys

0.006
-0.001-14.29%
Volume:837.07K
Turnover:5.02K
Market Cap:16.12M
PE:-2.36
High:0.006
Open:0.006
Low:0.006
Close:0.007
52wk High:0.011
52wk Low:0.003
Shares:2.69B
Float Shares:1.79B
Volume Ratio:0.15
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.003
EPS(LYR):-0.003
ROE:-98.32%
ROA:-17.79%
PB:3.71
PE(LYR):-2.36

Loading ...

Company Profile

Company Name:
Memphasys
Exchange:
ASX
Establishment Date:
2006
Employees:
24
Office Location:
34-36 Richmond Road,Level 1,Homebush,New South Wales,Australia
Zip Code:
2140
Fax:
- -
Introduction:
Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, as well as for artificial reproductive techniques for animals; and a polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited is headquartered in Homebush, Australia.